Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
2
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
22 competitors in Obesity
View Full LandscapeNo patent data available. Pre-approval drugs may not have Orange Book listings.
Acomplia
As an adjunct to diet and exercise for the treatment of obese patients (BMI 30 kg/m2), or overweight patients (BMI 27 kg/m2) with associated risk factor(s), such as type 2 diabetes or dyslipidaemia (see section 5.1).
View on EMAZimulti
As an adjunct to diet and exercise for the treatment of obese patients (BMI 30 kg/m2), or overweight patients (BMI 27 kg/m2) with associated risk factor(s), such as type 2 diabetes or dyslipidaemia (see section 5.1).
View on EMAType 2 Diabetes
Squamous Cell Lung Cancer
Type 2 Diabetes
Prostate Cancer
Multiple Myeloma
